Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03826320
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BZC | A | 1EFY | 0.71 | ||
E89 | 6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]- 1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN- 8-ONE | A,D | 1Y5X | 0.71 | |
T12 | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]- 1H-BENZIMIDAZOL-5-YL PIVALATE | A,B,C,D | 2NRU | 0.73 | |
1HP | 4-(2-amino-1-methyl-1H-imidazo[4,5- b]pyridin-6-yl)phenol | A,B | 2QSE | 0.71 | |
C1B | H | 2B7D | 0.72 | ||
TND | N-1,2,3,4-TETRAHYDRONAPHTH-1-YL- 2'-[3,5-DIMETHOXYBENZAMIDO]-2'- DEOXY-ADENOSINE | A,B,C,D,E,F | 1I33 | 0.71 | |
711 | 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN- 4-YL]OXY]-2-METHYL-BENZIMIDAZOL- 1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID | A | 1QBO | 0.72 | |
PU7 | 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)- 9H-PURIN-6-YLAMINE | A | 1UYC | 0.7 | |
ABO | 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H- INDAZOL-6-YL]-2-METHOXYPHENOL | A | 2C3K | 0.73 | |
L3G | N-(4-{4-AMINO-1-[1-(TETRAHYDRO- 2H-PYRAN-4-YL)PIPERIDIN-4-YL]-1H- PYRAZOLO[3,4-D]PYRIMIDIN-3-YL}- 2-METHOXYPHENYL)-1-METHYL-1H-INDOLE- 2-CARBOXAMIDE | A,B | 2C0T | 0.71 | |
NH8 | 3-{2-[(S)-(4-cyanophenyl)(hydroxy)(1- methyl-1H-imidazol-5-yl)methyl]- 5-nitro-1-benzofuran-7-yl}benzonitrile | A,B | 2ZIS | 0.77 | |
312 | 2-(5-{5-[AMINO(IMINIO)METHYL]-1H- BENZIMIDAZOL-2-YL}-2'-METHOXY-6- OXIDO-1,1'-BIPHENYL-3-YL)SUCCINATE | A | 1O2Z | 0.74 | |
688 | 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]- 6-[3-(4,5-DIHYDRO-1H-IMIDAZOL-2- YL)PHENOXY]PYRIDINE-4-CARBOXYLIC ACID | A | 1QBN | 0.71 | |
LIF | N-{4-[4-AMINO-6-(4-METHOXYPHENYL)FURO[2,3- D]PYRIMIDIN-5-YL]PHENYL}-N'-[2- FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA | A | 1YWN | 0.72 | |
NMD | N-NAPHTHALEN-1-YLMETHYL-2'-[3,5- DIMETHOXYBENZAMIDO]-2'-DEOXY-ADENOSINE | A,B,C,D,E,F | 1I32 | 0.73 | |
U49 | (20S)-19,20,21,22-TETRAHYDRO-19- OXO-5H-18,20-ETHANO-12,14-ETHENO- 6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3- K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE- 9-CARBONITRILE | A,B | 1LD8 | 0.71 | |
BNE | 2-[3-(3-ETHYL-1-METHYL-2-OXO-AZEPAN- 3-YL)-PHENOXY]-4-[1-AMINO-1-(1- METHYL-1H-IMIDIZOL-5-YL)-ETHYL]- BENZONITRILE | B | 1MZC | 0.71 | |
SU9 | (3Z)-3-(1H-IMIDAZOL-5-YLMETHYLENE)- 5-METHOXY-1H-INDOL-2(3H)-ONE | A | 1PF8 | 0.71 | |
VIN | 12-(2-hydroxyethyl)-2-(1-methylethoxy)- 13,14-dihydronaphtho[2,1-a]pyrrolo[3,4- c]carbazol-5(12H)-one | A | 3DTC | 0.71 | |
EZR | 3-methoxy-4-{3-[4-(4-methylpiperazin- 1-yl)-1H-benzimidazol-2-yl]-1H- indazol-6-yl}aniline | A | 3EZR | 0.71 | |
826 | 1,3,4,9-TETRAHYDRO-2-(HYDROXYBENZOYL)- 9-[(4-HYDROXYPHENYL)METHYL]-6-METHOXY- 2H-PYRIDO[3,4-B]INDOLE | A,B | 1I30 | 0.71 | |
6IN | 4-(1-BENZYL-3-CARBAMOYLMETHYL-2- METHYL-1H-INDOL-5-YLOXY)-BUTYRIC ACID | A | 1DB5 | 0.71 | |
IMA | [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL- BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}- METHYL)-PHENYL]-TRIMETHYL-AMMONIUM | B | 1LPG | 0.71 | |
IMA | [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL- BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}- METHYL)-PHENYL]-TRIMETHYL-AMMONIUM | A | 1LQE | 0.71 | |
330 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4- (2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE- 1,3(2H,6H)-DIONE | A | 2IO6 | 0.72 | |
310 | N-carbamimidoyl-2-[2-(2-chlorophenyl)- 5-[4-(4-ethanoylphenoxy)phenyl]pyrrol- 1-yl]ethanamide | A | 2ZDZ | 0.71 | |
133 | 6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY- PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE | B | 1GJ8 | 0.7 | |
BZ9 | N-[3-methyl-4-({3-[2-(methylamino)pyrimidin- 4-yl]pyridin-2-yl}oxy)naphthalen- 1-yl]-1H-benzimidazol-2-amine | A | 3DA6 | 0.71 | |
NH7 | 2-[(S)-(4-chlorophenyl)(hydroxy)(1- methyl-1H-imidazol-5-yl)methyl]- N-morpholin-4-yl-7-phenyl-1-benzofuran- 5-carboxamide | A,B | 2ZIR | 0.76 | |
E97 | [3-(4-{2'-[4-(3-DIMETHYLAMINO-PROPOXY)- PHENYL]-3H,3'H-[5,5']BIBENZOIMIDAZOLYL- 2-YL}-PHENOXY)-PROPYL]-DIMETHYL- AMINE | A | 1FTD | 0.73 | |
MBC | 2-(5-{4-[AMINO(IMINO)METHYL]PHENYL}- 2-FURYL)-1H-BENZIMIDAZOLE-5-CARBOXIMIDAMIDE | A | 2I2I | 0.75 | |
L1G | N-(4-{4-AMINO-1-[4-(4-METHYLPIPERAZIN- 1-YL)-TRANS-CYCLOHEXYL]-1H-PYRAZOLO[3,4- D]PYRIMIDIN-3-YL}-2-METHOXYPHENYL)- 1-METHYL-1H-INDOLE-2-CARBOXAMIDE | A,B | 2C0I | 0.72 | |
FRL | 1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)- 1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1WXZ | 0.72 | |
L2G | N-(4-{1-[4-(4-ACETYLPIPERAZIN-1- YL)-TRANS-CYCLOHEXYL]-4-AMINO-1H- PYRAZOLO[3,4-D]PYRIMIDIN-3-YL}- 2-METHOXYPHENYL)-1-METHYL-1H-INDOLE- 2-CARBOXAMIDE | A,B | 2C0O | 0.72 | |
3HT | 5-[1-(4-methoxyphenyl)-1H-benzimidazol- 6-yl]-1,3,4-oxadiazole-2(3H)-thione | A,B | 3F88 | 0.72 | |
HXL | 2-(4-(4-CARBAMIMIDOYLPHENOXY)PHENYL)- 1H-BENZO[D]IMIDAZOLE-6-CARBOXIMIDAMIDE | G | 2FJV | 0.7 | |
HXL | 2-(4-(4-CARBAMIMIDOYLPHENOXY)PHENYL)- 1H-BENZO[D]IMIDAZOLE-6-CARBOXIMIDAMIDE | B | 2FJX | 0.7 | |
PFP | 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3- D]PYRIMIDIN-4-YLAMINO]-ETHANOL | A | 2BR1 | 0.71 | |
R64 | (1-METHYL-1H-IMIDAZOL-2-YL)-(3- METHYL-4-{3-[(PYRIDIN-3-YLMETHYL)- AMINO]-PROPOXY}-BENZOFURAN-2-YL)- METHANONE | A,B,C | 1IYL | 0.76 | |
123 | 2-(2-HYDROXY-5-METHOXY-PHENYL)- 1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE | B | 1GI9 | 0.72 | |
123 | 2-(2-HYDROXY-5-METHOXY-PHENYL)- 1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE | A | 1GI5 | 0.72 |